Is it time that drug companies stop vaccine ads, marketing, publicity, and produce safety studies on vaccines’ ingredients singly, combined or cumulative with many vaccines?
The Chicago-area Nelson family would agree. After receiving chickenpox, human papilloma virus (HVP) and meningitis vaccinations, Shannon Nelson, 18, a freshman college student, suffered Guillain Barre Syndrome (GBS), paralysis of extremities. Within a week after three vaccine injections this summer, her finger, toes and tongue went numb. Numbness combined with progressive weakness caused her 22-day hospitalization.
Although she no longer needs a wheelchair or help to walk, Shannon says, “My smile is not as big as it was.” Sometimes, she needs to hold her lips to prevent liquid from dribbling out of her mouth. She now has partial feeling in her fingers which makes guitar playing difficult. Her doctors tell her it will take one to two years for her complete recovery.
According to her father, Shannon’s pediatrician, pediatric neurologist and infectious disease specialist all admit vaccines were at fault. They cannot tell the family if it were one vaccine or the combination that caused GBS. One of her doctors said she would have been on a respirator if she were not a healthy athlete, a former high school cross-country runner.
It was providential that Illinois’ legislators passed an information-only bill (SB 937), without the cervical cancer-HPV vaccination mandate for 11- to 12-year-old girls, that Gov. Blagojevich recently signed. Will the information include a reference to Shannon and the 14 other nationwide GBS cases after HPV injections?
Shannon stresses, “I know a lot more than I wanted to know about GBS. People deserve to know the facts.”
Barbara Alexander Mullarkey
President, Illinois Vaccines Awareness Coalition